Study of Front Line Therapy With Nivolumab and Salvage Nivolumab + Ipilimumab in Patients With Advanced Renal Cell Carcinoma
Clinical trial NCT03117309 · COMPLETED
Trial details
- NCT number
- NCT03117309
- Sponsor
- Michael B. Atkins, MD
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-24
- Primary completion
- 2022-03-25
- Enrollment
- 164
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.